Emergent BioSolutions
EBS
#8133
Rank
S$0.46 B
Marketcap
S$9.04
Share price
3.67%
Change (1 day)
-30.55%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$0.99 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are S$0.99 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$1.02 B-17.1%
2024-12-31S$1.23 B-20.49%
2023-12-31S$1.55 B-34.98%
2022-12-31S$2.38 B31.01%
2021-12-31S$1.81 B-4.21%
2020-12-31S$1.90 B13.76%
2019-12-31S$1.67 B0.33%
2018-12-31S$1.66 B688.22%
2017-12-31S$0.21 B-60.97%
2016-12-31S$0.54 B1.35%
2015-12-31S$0.53 B4.82%
2014-12-31S$0.50 B192.46%
2013-12-31S$0.17 B16.64%
2012-12-31S$0.14 B-11.4%
2011-12-31S$0.16 B3.22%
2010-12-31S$0.16 B15.3%
2009-12-31S$0.14 B8.3%
2008-12-31S$0.13 B-11.21%
2007-12-31S$0.14 B-3.74%
2006-12-31S$0.15 B126.37%
2005-12-31S$67.59 M-10.14%
2004-12-31S$75.21 M
2002-12-31S$32.33 M-69.74%
2001-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$148.06 B 14,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$112.44 B 11,225.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$75.60 B 7,514.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
S$4.9 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$13.37 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$86.79 M-91.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.10 B 4,039.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel